Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioLife Solutions Inc BLFS

BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are... see more

Recent & Breaking News (NDAQ:BLFS)

BioLife Solutions Launches the IntelliRate(TM) i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer

PR Newswire June 6, 2023

BioLife Solutions Reports First Quarter 2023 Financial Results

PR Newswire May 10, 2023

BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023

PR Newswire May 2, 2023

BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results

PR Newswire March 16, 2023

BioLife Solutions Reports Immaterial Financial Exposure to Silicon Valley Bank

PR Newswire March 10, 2023

BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023

PR Newswire March 9, 2023

BioLife Solutions Launches Ultraguard(TM) -70°C Phase Change Material (PCM) Accessory to Provide Backup Cooling in ULT Freezers and Dry Ice Alternative for Benchtop Biologic Material Storage

PR Newswire March 1, 2023

BioLife Solutions Announces 2023 Analyst Day & Participation in Upcoming Investor Conferences

PR Newswire January 17, 2023

BioLife Solutions Named One of Seattle Business Magazine's Washington's Best Companies to Work For

PR Newswire January 10, 2023

BioLife Solutions Announces 2022 Fourth Quarter and Full Year Preliminary Unaudited Revenue and Introduces 2023 Revenue Guidance

PR Newswire January 9, 2023

BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023

PR Newswire December 19, 2022

BioLife Solutions Expands Intellectual Property Estate

PR Newswire November 21, 2022

BioLife Solutions Named in BioSpace Best Places to Work in Biopharma 2023 Report

PR Newswire November 17, 2022

BioLife Solutions Reports Third Quarter 2022 Financial Results

PR Newswire November 9, 2022

BioLife Solutions to Report Third Quarter 2022 Financial Results and Provide Business Update on November 9, 2022

PR Newswire November 2, 2022

CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market

PR Newswire October 11, 2022

BioLife Solutions Announces COO to Retire and Join Board of Directors

PR Newswire October 3, 2022

BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors

PR Newswire August 25, 2022

BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance

PR Newswire August 9, 2022

BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022

PR Newswire August 2, 2022